These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Experiences with acinin Berna in cancer therapy]. LUDWIG W Hippokrates; 1954 May; 25(10):322-4. PubMed ID: 13174174 [No Abstract] [Full Text] [Related]
3. [Additional experiences with acinin Berna in the treatment of cancer]. KRETZ J Krebsarzt; 1954 Apr; 9(2):94-7. PubMed ID: 13193026 [No Abstract] [Full Text] [Related]
4. [Different forms of cancer treated with acinin]. JENTZER A Oncologia; 1953; 6(4):286-98. PubMed ID: 13154878 [No Abstract] [Full Text] [Related]
5. Immunogenicity and safety of BERNA-YF compared with two other 17D yellow fever vaccines in a phase 3 clinical trial. Pfister M; Kürsteiner O; Hilfiker H; Favre D; Durrer P; Ennaji A; L'Age-Stehr J; Kaufhold A; Herzog C Am J Trop Med Hyg; 2005 Mar; 72(3):339-46. PubMed ID: 15772332 [TBL] [Abstract][Full Text] [Related]
6. [Immunotherapy by polyvalent bacterial antigen (Broncasma Berna) in the prevention of pneumonia in the elderly]. Suzuki K; Yamamoto K; Adachi S; Yamamoto T Kansenshogaku Zasshi; 1989 Mar; 63(3):173-81. PubMed ID: 2504831 [TBL] [Abstract][Full Text] [Related]
7. [The ineffectiveness of acinin Bern as a cancer therapeutic in Ehrlich carcinoma in white mice]. WETZEL J Oncologia; 1953; 6(4):260-85. PubMed ID: 13154877 [No Abstract] [Full Text] [Related]
8. Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children. Feiterna-Sperling C; Brönnimann R; Tischer A; Stettler P; Durrer P; Gaedicke G Pediatr Infect Dis J; 2005 Dec; 24(12):1083-8. PubMed ID: 16371870 [TBL] [Abstract][Full Text] [Related]
9. Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines. Schwarzer S; Reibel S; Lang AB; Struck MM; Finkel B; Gerike E; Tischer A; Gassner M; Glück R; Stück B; Cryz SJ Vaccine; 1998; 16(2-3):298-304. PubMed ID: 9607046 [TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic suppurative otitis media with Broncasma Berna. Nakatani M Ear Nose Throat J; 2001 Aug; 80(8):529. PubMed ID: 11523469 [TBL] [Abstract][Full Text] [Related]
12. Effects of Broncasma Berna on chronic sinusitis and nasal allergy. Sato Y; Yoshida T; Sato M Poumon Coeur; 1982; 38(5):301-10. PubMed ID: 7156002 [TBL] [Abstract][Full Text] [Related]
14. [Effectiveness and tolerance of the rabies vaccine Lyssavac Berna]. Haenzel I; Schindler M; Inderbitzin TM Schweiz Med Wochenschr; 1976 Nov; 106(47):1637-41. PubMed ID: 1013686 [TBL] [Abstract][Full Text] [Related]
15. Patient compliance in the use of Vivotif Berna(R) vaccine, typhoid vaccine, live oral Ty21a. Cryz SJ J Travel Med; 1998 Mar; 5(1):14-7. PubMed ID: 9772310 [TBL] [Abstract][Full Text] [Related]
16. [The Mantoux test using Berna and Copenhagen tuberculins in comparison with the epicutaneous Mérieux Monotest in adults]. Scherrer R; De Carli A; Marsch S; Hany A Schweiz Med Wochenschr; 1987 Oct; 117(42):1628-32. PubMed ID: 3423757 [TBL] [Abstract][Full Text] [Related]
17. [2 years of oral diabetes therapy with Sucrida Berna]. BERINGER A Wien Med Wochenschr; 1962 Apr; 112():275-7. PubMed ID: 13867844 [No Abstract] [Full Text] [Related]